Brachytherapy for prostate cancer in 2010

Area of Science:

• Oncology
• Radiotherapy
• Urology

Background:

• Permanent prostate brachytherapy is an established treatment for localized prostate cancer.
• Radioactive isotope seed implantation is a common brachytherapy technique.

Purpose of the Study:

• To evaluate the long-term clinical outcomes of permanent prostate brachytherapy.
• To assess the impact of patient selection and implant quality on treatment success.
• To examine the preservation of erectile function following the procedure.

Main Methods:

• Review of clinical outcome data for patients treated with permanent prostate brachytherapy.
• Analysis of prostate-specific antigen (PSA) recurrence-free survival rates.
• Evaluation of factors influencing treatment success, including patient selection and implant quality.
• Assessment of erectile function outcomes, including the role of medical assistance.

Main Results:

• Mature clinical data demonstrate excellent long-term PSA recurrence-free survival exceeding 10 years for low-risk prostate cancer patients.
• Treatment outcomes are significantly influenced by appropriate patient selection and high-quality implants.
• Preservation of erectile function is achievable in younger, previously potent men, often supported by medical treatments.

Conclusions:

• Permanent prostate brachytherapy is a highly effective treatment for localized prostate cancer, providing durable long-term cancer control.
• Meticulous patient selection and precise implant technique are critical for optimizing treatment efficacy and patient outcomes.
• Sexual function can be maintained in select patient groups, enhancing overall quality of life post-treatment.